SCHEMBL20373216

SCHEMBL20373216

COc1ccc(CC(=O)Nc2nnc(NC3CCN(c4cccnn4)C3)s2)cc1

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 19/20 0.81
▸ KCNH2 Q12809 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20373637 0.89 GLS (1.00) GLSKCNH2
SCHEMBL18946049 0.89 GLS (0.85) GLSKCNH2
SCHEMBL18945962 0.85 GLS (0.81) GLSKCNH2
SCHEMBL29462506 0.85 GLS (0.78) GLSKCNH2
SCHEMBL20357668 0.84 GLS (1.00) GLS
SCHEMBL19097732 0.84 GLS (1.00) GLS
SCHEMBL22193574 0.84 GLS (0.89) GLSKCNH2
SCHEMBL17309176 0.83 GLS (1.00) GLS
SCHEMBL17309183 0.83 GLS (1.00) GLS
SCHEMBL22006503 0.82 KCNH2 (0.80) GLSKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148994-B1 1, 3, 4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2018-07-11 — — EP disclosed
Send feedback